{
    "Trade/Device Name(s)": [
        "LupoTek Detectin VL",
        "LupoTek Correctin VL",
        "PlasmaCon LA"
    ],
    "Submitter Information": "r2 Diagnostics, Inc.",
    "510(k) Number": "K083878",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061805",
        "K935254"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GIR",
        "GGC"
    ],
    "Summary Letter Date": "April 21, 2010",
    "Summary Letter Received Date": "April 22, 2010",
    "Submission Date": "23 Jun 2010",
    "Regulation Number(s)": [
        "21CFR864.8950",
        "21CFR864.5425"
    ],
    "Regulation Name(s)": [
        "Russell viper venom reagent",
        "Abnormal control plasma"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "immunology"
    ],
    "Analyte(s)": [
        "Lupus anticoagulants"
    ],
    "Specimen Type(s)": [
        "Citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Dilute Russell's viper venom method"
    ],
    "Methodologies": [
        "Qualitative clotting assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for LupoTek Detectin VL, LupoTek Correctin VL, and PlasmaCon LA for detection and quality control of lupus anticoagulants in citrated human plasma using dilute Russell's viper venom method",
    "Indications for Use Summary": "Qualitative detection of lupus anticoagulants in citrated human plasma and use of LA positive abnormal plasma as a quality control to monitor diagnostic assay performance in professional clinical laboratories",
    "fda_folder": "Hematology"
}